Viva Biotech Holdings (1873.HK)

HKD 0.89

(-2.2%)

Total Liabilities Summary of Viva Biotech Holdings

Viva Biotech Holdings's latest annual total liabilities in 2023 was 3.76 Billion CNY , down -12.84% from previous year.
Viva Biotech Holdings's latest quarterly total liabilities in 2024 Q2 was 3.37 Billion CNY , down 0.0% from previous quarter.
Viva Biotech Holdings reported annual total liabilities of 4.31 Billion CNY in 2022, up 4.47% from previous year.
Viva Biotech Holdings reported annual total liabilities of 4.13 Billion CNY in 2021, down -6.05% from previous year.
Viva Biotech Holdings reported quarterly total liabilities of 3.76 Billion CNY for 2023 Q4, down 0.0% from previous quarter.
Viva Biotech Holdings reported quarterly total liabilities of 3.76 Billion CNY for 2023 FY, down -12.84% from previous quarter.

Annual Total Liabilities Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Total Liabilities of Viva Biotech Holdings (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	3.76 Billion CNY	-12.84%
2022	4.31 Billion CNY	4.47%
2021	4.13 Billion CNY	-6.05%
2020	4.39 Billion CNY	3522.38%
2019	121.39 Million CNY	-56.32%
2018	277.89 Million CNY	459.82%
2017	49.64 Million CNY	96.06%
2016	25.31 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.37 Billion CNY	0.0%
2023 Q4	3.76 Billion CNY	0.0%
2023 FY	3.76 Billion CNY	-12.84%
2023 Q2	4.5 Billion CNY	0.0%
2022 FY	4.31 Billion CNY	4.47%
2022 Q4	4.31 Billion CNY	0.0%
2022 Q2	4.22 Billion CNY	0.0%
2021 Q2	4.11 Billion CNY	0.0%
2021 FY	4.13 Billion CNY	-6.05%
2021 Q4	4.13 Billion CNY	0.0%
2020 Q4	4.39 Billion CNY	0.0%
2020 FY	4.39 Billion CNY	3522.38%
2020 Q2	1.39 Billion CNY	0.0%
2019 Q4	121.39 Million CNY	0.0%
2019 Q2	118.48 Million CNY	0.0%
2019 FY	121.39 Million CNY	-56.32%
2018 Q4	277.89 Million CNY	0.0%
2018 FY	277.89 Million CNY	459.82%
2017 FY	49.64 Million CNY	96.06%
2016 FY	25.31 Million CNY	0.0%

Peer Total Liabilities Comparison of Viva Biotech Holdings

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-2361.752%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	46.7%